LicianPro

BCTX stock

Briacell Therapeutics Corp (BCTX) short interest & short volume · 13.7% of float short

Briacell Therapeutics Corp official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

BCTX short interest rose 1.3% to 789K shares in the Oct 15, 2026 report (13.7% of float, 14.2 days to cover). Daily short volume averaged 58.1% of volume over the last 20 sessions, up from 55.1% the 20 sessions before, the 82nd percentile of its own 20-day averages since Oct 6, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
789K
prior 779K
% of float
13.7%
float 5.8M
Days to cover
14.2
avg vol 55K
Change vs prior report
+1.3%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

BCTX short interest by FINRA report (last 6) · price is the close on the report date
Report dateShares short$ value shortChange% floatDays to coverPrice
Oct 15, 2026789K$3.0M+1.3%13.7%14.2$3.77
Sep 30, 2026779K$3.3M-1.7%13.5%3.9$4.28
Sep 15, 2026792K$2.8M+9.4%13.7%8.6$3.58
Aug 31, 2026724K$2.6M+81.5%12.5%1.0$3.59
Aug 14, 2026399K$1.4M-2.3%6.9%3.3$3.44
Jul 31, 2026408K$1.4M-8.9%7.1%6.0$3.44

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 11)
75.0%
26K of 35K
20-day average
58.1%
prior 55.1%
Percentile vs own history
82nd
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 11, 2026

Short squeeze score (model)

Price since settlement: -6.9%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

BCTX's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · BCTX overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-1126,46835,26675.0%
2026-11-105,12217,07230.0%
2026-11-0927,59749,89655.3%
2026-11-0668,44498,31169.6%
2026-11-0528,82557,02450.5%
2026-11-0423,41736,28864.5%
2026-11-0315,23426,15258.3%
2026-11-029,48322,41442.3%
2026-10-3024,43649,61149.3%
2026-10-2911,03528,75638.4%

Healthcare peers with similar quant ratings

BCTX among 545 rated Healthcare stocks (Lician quant rating, Nov 13, 2026). How the rating works

BCTX short interest FAQ

What is BCTX's short interest?

Briacell Therapeutics Corp (BCTX) had 789K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 13.7% of its 5.8M-share float.

How many days to cover does BCTX have?

14.2 days: 789K shares short divided by an average daily volume of 55K for the Oct 15, 2026 period.

Is BCTX short interest rising or falling?

BCTX short interest rose (+1.3%) from 779K to 789K shares in the Oct 15, 2026 report.

Is BCTX a short squeeze candidate?

Lician's squeeze watch scores BCTX 44 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 18.2/40, days to cover 25/25, change in short interest vs prior report 0.4/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of BCTX daily volume is sold short?

58.1% on average over the last 20 sessions to Nov 11, 2026 (FINRA Reg SHO daily short volume; the 82nd percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was BCTX's latest FINRA short volume?

On Nov 11, 2026, cached FINRA short volume for Briacell Therapeutics Corp (BCTX) was 26,468 shares, 75.0% of 35,266 total volume.

How many BCTX short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Briacell Therapeutics Corp (BCTX), from Oct 29, 2026 through Nov 11, 2026.

How did BCTX short volume percent change from the prior cached session?

Cached FINRA short volume for Briacell Therapeutics Corp (BCTX) moved from 30.0% on Nov 10, 2026 to 75.0% on Nov 11, 2026, up 45.0 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.